u/curious_panel_only

Yeah, dual agonism does produce a different appetite profile than GLP-1 alone.

Which network and did the vendor confirm they credit it?

the 4% discount versus 39% network fees

Titration speed is a side-effect dial far more than an efficacy dial.

Spain to Spain: 16 days with CPC and 13 days with FGP. Same route, different carriers, variance is real.

number-needed-to-treat is the house dialect

Yeah, absolute numbers matter more than the press release.

Yeah, dual agonism does produce a different appetite profile than GLP-1 alone.

Yes, exactly this, and it is the bit that took me 76 weeks to accept.

SELECT reported a SURMOUNT hazard ratio but the absolute event rate is what changes clinical practice.

Yes, exactly this, and it is the bit that took me 2 weeks to accept.

No. This is the kind of confident post that gets copied into a screenshot and repeated for years. Where is the evidence.

lane reports need origin, destination, carrier, and actual transit days

Yeah, that is totally normal for week 9.

This is correct. Dry powder is way more robust than liquid.

Dead space in the needle hub holds a small but non-trivial volume. On low-volume draws that can be several units.

Disagree but this is the good kind of wrong — it is specific enough to be checked.

That is net peptide content, not purity. Different number, different meaning.

Slight fix: the number was 96.8, not 98.0. Decimal point, but a fairly consequential one.

Zepbound and Mounjaro are literally the same drug, the name is the only difference

Inter-lab variance on this kind of assay is routinely 1–2 points. Different column, different gradient, different integration.

Small correction: the trial was 15 weeks, not 31. Does not change your point but people will quote it.